Abstract:In the author's institution, 2254 patients with hepatocellular carcinoma (HCC) have been treated during 1958-1994. The overall 5-year survival increased from 5.4% (1958-1970), to 11.9% (1971-1982), to 46.2% (1983-1984), which correlated well with the increasing proportion of small HCC in the series (2.6%, 12.1%, and 33.4%, respectively); with the increasing percentage of limited resection (3.1%, 32.2%, and 58.3%); with the increasing number of re-resections for recurrence (0, 27, and 114 patients); and with the increasing number of second stage resections (0, 5, and 67 patients). In our institution, surgical approaches that resulted in significantly prolonging survival included: small HCC resection, re-resection, and cytoreduction followed by sequential resection for initially unresectable HCC. Experience in these 3 aspects suggests: (a) Small HCCs are mainly found by screening using AFP and ultrasonography (US) in a high risk population, and limited resection is the best treatment in patients with compensated liver cirrhosis, the 5-year survival after resection being 62.9% (n = 549). (b) Postoperative monitoring using AFP/US every 2-3 months for 5-10 years after curative resection is needed to detect subclinical recurrence. Limited re-resection is indicated for liver recurrence less than 3 nodules, and lung lobectomy is of proven merit to prolong survival for solitary lung metastasis. Re-resection of subclinical recurrence has resulted in a 10-20% further increase in 5-year survival after curative resection. (c) Palliative surgery other than resection such as hepatic artery ligation (HAL) and cannulation with arterial infusion (HAI), cryosurgery, etc. are superior to palliative resection with residual cancer. (d) Cytoreduction and sequential resection have provided hope for localized unresectable HCC, particularly in the right cirrhotic liver. Multimodality combination treatments such as HAL+HAI+radioimmunotherapy/regional radiotherapy are acceptable cytoreductive therapies. Repeated transcatheter hepatic arterial chemoembolization (TACE) is an alternative nonsurgical approach. Sequential resection is important to eradicate residual cancer after cytoreduction. The 5-year survival of 72 patients with cytoreduction and sequential resection for initially unresectable HCC was 62.1% and resulted in improving 5-year survival in the entire series of unresectable HCC over the 3 periods from 0% to 7.4% to 25.7%, respectively. However, multicentric origin and tumor invasiveness are two major targets to be studied in the control of recurrence and metastasis.

Cytoreduction and Sequential Resection - A Hope for Unresectable Primary Liver-Cancer

Treatment of unresectable primary liver cancer: With reference to cytoreduction and sequential resection

Systematic sequential therapy for <i>ex vivo</i> liver resection and autotransplantation: A case report and review of literature

The Paradigm of Tumor Shrinkage and Rapid Liver Remnant Hypertrophy for Conversion of Initially Unresectable Colorectal Liver Metastasis: a Case Report and Literature Review

Efficacy of conversion therapy on future liver remnant hypertrophy for initially unresectable colorectal liver metastases: a review of current status and perspectives

Cytoreduction and Sequential Resection for Surgically Verified Unresectable Hepatocellular Carcinoma: Evaluation with Analysis of 72 Patients

[Ten-Year Retrospect of ALPPS in the Treatment of Hepatocellular Carcinoma:An Eternal Concept with Cautious Technologic Choice].

Surgery for Primary Liver Cancer: A Forty Years Survey

Multimodality Treatment in Advanced Primary Liver Cancer.

Three Decades of Progress in Surgery for Primary Liver Cancer

Hepatic Artery Ligation and Infusion Chemotherapy for Unresectable Primary Liver Cancer.

Three Decades' Experience In Surgery Of Hepatocellular Carcinoma

Prognostic Factors Of Primary Liver-Cancer - Report Of 83 Patients Surviving 5 Years Or More Compared With 811 Patients Surviving Less Than 5 Years

Long-term Survivors after Resection for Primary Liver Cancer. Clinical Analysis of 19 Patients Surviving More Than Ten Years

The Role of Targeting Therapy in Cytoreduction and Sequential Resection of Unresectable Hepatocellular Carcinoma

Primary Tumor Resection for Rectal Cancer With Unresectable Liver Metastases: A Chance to Cut Is a Chance for Improved Survival

Surgical treatment of liver cancer with insufficient future liver remnant: controversy and consensus

Long-term Results of Surgery for Small Primary Liver Cancer in 514 Adults

The Changing Role of Surgery in the Treatment of Primary Liver Cancer

The comprehensive therapy for primary liver cancer

Conversion of Surgically Verified Unresectable to Resectable Hepatocellular Carcinoma